FDA concerned about unapproved products for sexual enhancement

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2006年 / 1111卷 / 1期

关键词：

Public Health; Blood Pressure; Nitrate; Chemical Analysis; Healthcare Provider;

D O I：

10.2165/00128415-200611110-00004

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：2 / 2

相关论文

共 50 条

[1] FDA against marketing unapproved quinine products
Reactions Weekly, 2007, 1133 (1) : 3 - 3
[2] FDA goes after unapproved equine products
不详
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2015, 246 (01): : 28 - 28
[3] FDA warns companies over unapproved chelation products
Reactions Weekly, 2010, 1324 (1) : 2 - 2
[4] FDA warns makers of unapproved 'tear stain' products
不详
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2014, 245 (08): : 876 - 876
[5] FDA warning companies not to sell unapproved cannabidiol products
Reactions Weekly, 2021, 1850 (1) : 5 - 5
[6] FDA policy on unapproved drug products: Past, present, and future
Chhabra, R
Krernzner, ME
Kiliany, BJ
ANNALS OF PHARMACOTHERAPY, 2005, 39 (7-8) : 1260 - 1264
[7] FDA concerned about safety of disodium edetate
Reactions Weekly, 2008, 1186 (1) : 2 - 2
[8] Marketing of unapproved drug products must stop - US FDA
Reactions Weekly, 2008, 1222 (1) : 4 - 4
[9] FDA issues warning letters about unapproved eye disorder therapies
Reactions Weekly, 2023, 1975 (1) : 6 - 6
[10] AAPT CONCERNED ABOUT FDA LASER-SAFETY RULES
不详
PHYSICS TODAY, 1974, 27 (08) : 63 - 63

← 1 2 3 4 5 →